Day: July 9, 2020

AUSTIN, Texas, July 09, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial stage biotech company, CEO Denis Corin, who discusses the development of the Company’s exclusive Named Patient Program distribution agreement for its non-opioid metastatic cancer bone pain drug, Strontium89, with Caligor Coghlan Pharma Services (CCPS) for the ex-U.S. marketThe full interview can be heard at: https://www.smallcapvoice.com/7-8-20-smallcapvoice-interview-q-biomed-qbio/Speaking with SCV’s Stuart Smith, Corin explains that an estimated ten million people around the world suffer from pain associated with metastatic cancer in the bone and can benefit from Strontium89. The distribution agreement provides global access to this important...

DALLAS, July 09, 2020 (GLOBE NEWSWIRE) — The Board of Directors of CSW Industrials, Inc. (Nasdaq: CSWI) today declared a regular quarterly cash dividend of $0.135 per share. The dividend is payable on August 14, 2020, to shareholders of record as of the close of business on July 31, 2020.About CSW IndustrialsCSWI is a diversified industrial growth company with well-established, scalable platforms and domain expertise across two segments: Industrial Products and Specialty Chemicals. CSWI’s broad portfolio of leading products provides performance optimizing solutions to its customers. CSWI’s products include mechanical products for heating, ventilation, air conditioning and refrigeration (“HVAC/R”) applications, sealants, and high-performance specialty lubricants. Markets that CSWI serves include: HVAC/R, architecturally-specified...

BEIJING, July 09, 2020 (GLOBE NEWSWIRE) — ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced that it has received a letter from the Nasdaq Listing Qualifications Staff notifying the Company that it has regained compliance with the minimum bid price requirement under the Listing Rules of The Nasdaq Stock Market. The letter noted that as a result of the closing bid price of the Company’s common stock having been at $1.00 per share or greater for at least 10 consecutive business days, from June 22, 2020, to July 6, 2020, the Company has regained compliance with Listing Rule 5550(a)(2), and the matter is now closed.About ATA Creativity GlobalATA...

A randomized, controlled, multi-center study designed to demonstrate better disease control, reduced retinal damage and a reduction in treatment frequencycompared to current standard of careCompany to host Conference Call on July 15, 2020 to discuss study protocol and implicationsATLANTA, July 09, 2020 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, today announced the initiation of the company’s NEW DAY clinical trial, a randomized, controlled, multi-center study designed to generate prospective data for ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg as a baseline therapy in patients diagnosed with diabetic macular edema (DME)....

WASHINGTON and RICHMOND, Calif., July 09, 2020 (GLOBE NEWSWIRE) — The Army Distaff Foundation (ADF), a non-profit charity in Washington, D.C., which operates Knollwood Military Life Plan  Community, is the first life plan community to adopt the use of Ekso Bionics’ (Nasdaq: EKSO) robotic exoskeleton for rehabilitation with aging adult populations.As part of its comprehensive fall prevention program, ADF has invested in and implemented new technology and innovation like the EksoGT exoskeleton device. The exoskeleton is designed to help patients stand and walk during physical therapy after a stroke, acquired brain injury, or spinal cord injury.Through the program, ADF began trialing the use of EksoGT for rehabilitation with older adults at Knollwood in February 2018. Thirty people completed the EksoGT therapy, which has improved gait,...

RENO, Nev., July 09, 2020 (GLOBE NEWSWIRE) — Diego Pellicer Worldwide, Inc. (OTCQB: DPWW), a premium marijuana brand and retail development company, today announced that its Denver licensee reported its 2020 second quarter fiscal results with a 24 percent increase in year-over-year gross receipts and 38 percent increase over the first quarter of 2020.“High quality products, incredible value and outstanding customer service in a clean and socially distant, world-class environment make for a winning formula. These second quarter numbers are impressive and a testament to the power of the Diego Way,” said Nello Gonfiantini III, chief executive officer, Diego Pellicer Worldwide, Inc. “We’re very pleased that customers continue to turn to Diego Pellicer for a premium experience and applaud all the employees for their diligence in providing...

DAYTONA BEACH, Fla., July 09, 2020 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. (NYSE:BRO), and James Nelson and Lynn Meyer, the owners of First Resource, Inc. (“First Resource”), today announced that Brown & Brown Dealer Services (“BBDS”) has acquired substantially all of the assets of First Resource. Since 2004, First Resource has been assisting its dealer partners to better serve their valued clientele by providing strategies around F&I performance management, sales training and F&I product solutions.  James and Lynn will continue to lead the First Resource operation from New Braunfels, Texas.  First Resource will become part of Brown & Brown Dealer Services, which operates under the leadership of Mike Neal.Mike stated, “James and Lynn have been involved in the...

BEIJING, July 09, 2020 (GLOBE NEWSWIRE) — Secoo Holding Limited (“Secoo” or the “Company”) (NASDAQ: SECO), Asia’s largest online integrated upscale products and services platform, today announced that it will report its first quarter 2020 unaudited financial results, on Thursday, July 16, 2020, before the open of U.S. markets.The Company’s management will host an earnings conference call at 8:00 AM U.S. Eastern Time on July 16, 2020 (8:00 PM Beijing/Hong Kong time on July 16, 2020).To speed up the entry process for participants, this earnings conference call requires all participants to finish an online registration in advance.For participants who wish to join the call, please complete the Direct Event online registration at http://apac.directeventreg.com/registration/event/6671729 at least 15 minutes prior to the scheduled...

SEATTLE, July 09, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT)  a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the second quarter ended June 30, 2020 after market close on Monday, August 10, 2020. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.Live audio of the webcast will be available on the “Investors” section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event.About Adaptive BiotechnologiesAdaptive Biotechnologies is a commercial-stage biotech company focused on harnessing...